Trial intelligence / Profile preview

SPAXIM: Infliximab and Methotrexate in Ankylosing Spondylitis

NCT00507403Phase 4Completed

Sponsor
University Hospital Tours
Start
Oct 2007
Primary completion
Oct 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of methotrexate in ankylosing spondylitis (AS), sponsored by University Hospital Tours. Started Oct 2007; status: completed.

02

Drugs

methotrexate
03

Conditions

ankylosing spondylitis (AS)

Beyond the preview

Go deeper on NCT00507403.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00507403.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call